HOME › DRUGS › DARBEPOETIN ALFA
ACTIVE SUBSTANCE / INN

DARBEPOETIN ALFA

Brand name(s): Aranesp, ARANESP, Nespo
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
AUTHORISED
Anemia;Cancer;Kidney Failure, Chronic
Kidney Failure, Chronic;Anemia;Cancer
ACTIVE SUBSTANCE
Darbepoetin Alfa
REGULATORS
FDA · EMA
SPONSORS / MAH
AMGEN, Amgen Europe B.V., Dompé Biotec S.p.A.
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ARANESPBLA103951AMGENPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AranespAmgen Europe B.V.Authorised08/06/2001Anemia;Cancer;Kidney Failure, Chronic
NespoDompé Biotec S.p.A.Withdrawn08/06/2001Kidney Failure, Chronic;Anemia;Cancer

FULL INTELLIGENCE ON DARBEPOETIN ALFA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →